Interní Med. 2014; 16(4): 159-162

Herpes zoster virus and ocular involvement

MUDr.Helena Štrofová1, doc.MUDr.Petra Svozílková, Ph.D.2
1 Soukromá oční ambulance &ndash, Ophthos s. r. o., Praha
2 Oční klinika, 1. lékařská fakulta, Univerzita Karlova v Praze a VFN v Praze

The Herpes zoster virus is DNA virus. After the initial infection has been treated, the virus remains dormant in a ganglion until reactivation

of the latent virus resulting in shingles – Herpes zoster. Herpes zoster ophthalmicus is defined as a classic dermatomal rash in the

ophthalmic division of the trigeminal nerve. It represents approximately 10 to 25 percent of all cases of herpes zoster. Patients with

herpes zoster may develop conjunctivitis, keratitis, uveitis and retinal disorders. Lasting effects of this infection may include chronic

eye inflammation, neuropathic pain or even loss of vision. Antiviral drugs such as aciclovir, famciclovir and valaciclovir remain the

mainstay of treatment and can be effective in preventing ocular disability if treatment is started within 72 hours after the onset of skin

manifestations. Early diagnosis and treatment of ophthalmic herpes zoster are important prevention of visual impairment. When skin

manifestation is present it is advised to also run appropriate ophthalmological examinations. This work deals with the herpes zoster

virus, the clinical picture, diagnosis and therapy.

Keywords: Herpes zoster virus, herpes zoster ophthalmic, keratitis, uveitis, retinitis, antiviral drugs

Published: June 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štrofová H, Svozílková P. Herpes zoster virus and ocular involvement. Interní Med. 2014;16(4):159-162.
Download citation

References

  1. Shaikh, S., Christopher, N.TA. Evaluation and Management of Herpes Zoster Ophthalmicus. Stanford University Medical Center, Stanford, California, Am Fam Physician. 2002 Nov 1;66 (9): 1723-1730.
  2. Kanski, J.J. Clinical Ophtalmology a systematic approach. 6th edition. Elsevier limited, 2007, s. 262-270, 477-482.
  3. Rozsíval, P. a spol. Infekce oka. Praha: Grada Publishing, a.s., 2003, 228 s.
  4. Kuchynka, P. a kol. Oční lékařství. Praha: Grada Publishing, a.s. 2007, s. 2-6, 186, 226-230, 435-438.
  5. Pavan-Langston, D. et al. Advances in the management of ocular herpetic disease. Florida. 2011, 20 s.
  6. Kolektiv autorů. Diagnostika a léčba očních chorob v praxi. The Wills eye manual. Praha: Triton, 2004, 620 s.
  7. Boguszaková, J., Říhová, E., Krásný, J. Oční záněty. Praha: Maxdorf, 2007, 96 s.
  8. Jeníčková, D. Infekční uveitidy. In: Říhová, E. a kol. Uveitidy. Praha: Grada Publishing, a.s., 2009, s. 27-32.
  9. Čihák, R. a kol. Periferní nervy. In: Čihák, R. a kol. Anatomie 3. Praha: Grada Publishing, a.s., 2009, s. 473-475.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.